New York, NY, US • 250 - 499 Employees
BioTech/Drugs
TG Therapeutics is a New York-based commercial-stage biopharmaceutical company that develops and markets novel therapies to treat cancer and autoimmune diseases.
Biotechnologyhematological malignanciesTGTX-1101 (ublituximab)non-Hodgkin's lymphomanon-Hodgkin's lymphomaB2BBiotechSaaSCommercial Physical Research